Correlation between Serotonin Concentration and Blood Pressure in Kidney Transplant Recipients Treated with Cyclosporine

Nephron

Volumn 72, Issue 2, 1996, Pages 336-337

  Azzadin, A ^a   Malyszko, J ^a   Malyszko, J S ^a   Buczko, W ^a   Mysliwiec, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; IMMUNOSUPPRESSIVE AGENT; PROSTACYCLIN; SEROTONIN; THROMBOXANE A2;

BLOOD PRESSURE; CELL LEVEL; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOASSAY; KIDNEY GRAFT; LETTER; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SPECTROFLUOROMETRY; SYMPATHETIC TONE; THROMBOCYTE;

BLOOD PRESSURE; CYCLOSPORINE; GRAFT REJECTION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; SEROTONIN; SEROTONIN AGONISTS;

EID: 0030060669     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188874     Document Type: Article

References (12)

1. McNally PG. Fcehally J: Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 1992;7:791-804.
2. Dos SO: Nephrotoxicity of cyclosporine: The role of platelet-activating factor and thromboxane. Lipids 1991;26:1320-1323.
3. Curtis JJ: Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 1992:2:2-8.
4. Kon V. Sugiura R. Inagami T. Harvie R. Ichikawa I. Hoover RL: Role of endothelin in cvclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-1491.
5. Fetkovska N. Pletscher A. Ferracin F, Amstcin R. Buhler FR: Impaired uptake of 5-hydroxy-tryptamine platelet in essential hypertension: Clinical relevance. Cardiovasc Drug Ther 1990;1:105-109.
6. Mysliwiec M, Azzadin A. Pawlak D. Szewczuk J. Buezko W: Cyclosporin A induced increase in blood pressure correlated with increase in blood serotonin. Vth Cong Soc Organ Transplant. Maastricht. October 1991.
7. Ueda D. Suzuki K. Malyszko J. Pictraszek MH. Takada Y. Takada A, Kawabe K: Fibrinolysis and serotonin under cyclosporine A treatment in kidney transplant recipients. Thromb Res 1995:75:99-105.
8. Drummond AH, Gordon J: Rapid, sensitive microassay for platelet serotonin. Thromb Diatli Haemorrh 1974:31:366-367.
9. Edwards BS. Hunt SA. Fowler MB, Valamine HA, Anderson LM, Lerman A: Effect of cyclosporin on plasma endothelin levels in human after cardiac transplantation. Am J Cardiol 1991;67:782-784.
10. deNucci G. Thomas R. d'Orlcans-Juste P, An-lunes E, Walder C. Warner TD. Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Nall Acad Sci USA 1988:85:9797-9800.
11. Brown Z. Neild GH. Willoughby JJ, Somia NV, Cameron JS: Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. T ransplantation 1986:42:150-153.
12. van Nuetcn JM, Janssens WJ, Vanhoutte PM: Serotonin and the Cardiovascular System. New York, Raven Press, 1985.